(Q79339786)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14652558%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

review article

1 reference

title

Familial adenomatous polyposis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14652558%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

Marcia Cruz-Correa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14652558%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Francis M Giardiello

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14652558%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

English

0 references

publication date

1 December 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14652558%20AND%20SRC:MED&resulttype=core&format=json

Gastrointestinal Endoscopy

21 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14652558%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14652558%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14652558%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

885-894

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14652558%20AND%20SRC:MED&resulttype=core&format=json

Identification of FAP locus genes from chromosome 5q21

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Hereditary benign and malignant lesions of the large bowel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Phenotypic expression of disease in families that have mutations in the 5' region of the adenomatous polyposis coli gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

The risk of upper gastrointestinal cancer in familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Desmoid tumours in familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Risk of hepatoblastoma in familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Dental anomalies in familial adenomatous polyposis coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

A clinicopathologic study of the eyes in familial adenomatous polyposis with extracolonic manifestations (Gardner's syndrome)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Nasopharyngeal angiofibroma in patients with familial adenomatous polyposis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Analysis of masked mutations in familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

The molecular basis of Turcot's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Incidence of associated diseases in familial polyposis coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Upper gastrointestinal pathology in familial adenomatous polyposis: results from a prospective study of 102 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Gastroduodenal lesions in familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Upper intestinal surveillance in familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Natural history of gastric adenomas in patients with familial adenomatosis coli/Gardner's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Upper gastrointestinal cancer in patients with familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Duodenal adenomatosis in familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Gastric and duodenal polyps in familial adenomatous polyposis: a prospective study of the nature and prevalence of upper gastrointestinal polyps

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Gastroduodenal polyps in patients with familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

The natural history of untreated duodenal and ampullary adenomas in patients with familial adenomatous polyposis followed in an endoscopic surveillance program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Management of duodenal adenomas in 98 patients with familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

The influence of mutation site and age on the severity of duodenal polyposis in patients with familial adenomatous polyposis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Mortality in patients with familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Desmoids in familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3' APC gene mutation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Desmoid tumours complicating familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Desmoid tumors in familial polyposis coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Spontaneous mesenteric fibromatosis in Gardner's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

APC gene mutations and extraintestinal phenotype of familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Genotype-phenotype correlations in attenuated adenomatous polyposis coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

APC gene: database of germline and somatic mutations in human tumors and cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Localization of the gene for familial adenomatous polyposis on chromosome 5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Correlation between the development of extracolonic manifestations in FAP patients and mutations beyond codon 1403 in the APC gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Pigmented ocular fundus lesions and APC mutations in familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

American Gastroenterological Association medical position statement: hereditary colorectal cancer and genetic testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

AGA technical review on hereditary colorectal cancer and genetic testing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Colorectal cancer screening: clinical guidelines and rationale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Hepatoblastoma and APC gene mutation in familial adenomatous polyposis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Rectal cancer risk in older patients with familial adenomatous polyposis and an ileorectal anastomosis: a cause for concern

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Primary chemoprevention of familial adenomatous polyposis with sulindac

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Randomized, placebo-controlled trial of gastric acid-lowering therapy on duodenal polyposis and relative adduct labeling in familial adenomatous polyposis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Clinicopathologic features and endoscopic resection of duodenal adenocarcinomas and adenomas with the submucosal saline injection technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Surgical polypectomy of duodenal adenomas in familial adenomatous polyposis: experience of two European centres.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Endoscopic treatment of ampullary adenomas in familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Photodynamic therapy for polyps in familial adenomatous polyposis--a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Pancreas-sparing duodenectomy: indications, surgical technique, and results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Surgical treatment of severe duodenal polyposis in familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Villous tumors of the duodenum: reappraisal of local vs. extended resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Familial adenomatous polyposis: efficacy of endoscopic and surgical treatment for advanced duodenal adenomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Mesenteric desmoid tumor in Gardner's syndrome treated by sulindac

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Use of doxorubicin and dacarbazine for the management of unresectable intra-abdominal desmoid tumors in Gardner's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Testolactone, sulindac, warfarin, and vitamin K1 for unresectable desmoid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Treatment of Intra-abdominal and Abdominal Wall Desmoid Tumors With Drugs That Affect the Metabolism of Cyclic 3', 5'-Adenosine Monophosphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Desmoid tumours treated with triphenylethylenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Nonsteroid antiinflammatory drugs and tamoxifen for desmoid tumors and carcinoma of the stomach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Treatment of mesenteric desmoid tumours with the anti-oestrogenic agent toremifene: case histories and an overview of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Indomethacin and ascorbate inhibit desmoid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Combination chemotherapy in adult desmoid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Successful treatment of a desmoid tumor with doxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Combination chemotherapy for desmoid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Extended follow-up of patients treated with cytotoxic chemotherapy for intra-abdominal desmoid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Desmoid tumors: a novel approach for local control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Percutaneous chemical ablation of desmoid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Desmoid tumors and their management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Extracolonic manifestations of familial polyposis coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

Combined surgical resection and iridium 192 implantation for locally advanced and recurrent desmoid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

The efficacy of radiotherapy as postoperative treatment for desmoid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

The desmoid tumor. Not a benign disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2803%2902336-8

10.1016/S0016-5107(03)02336-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14652558%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference